HEADACHE MEETING: New Data Confirm Rapid Onset of Action With Zomig For Migraine
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




HEADACHE MEETING: New Data Confirm Rapid Onset of Action With Zomig For Migraine

BARCELONA, SPAIN -- June 25, 1999 -- Data from a new study comparing two of the newer 'triptans', Zomig™ (zolmitriptan, AstraZeneca) 2.5mg and rizatriptan 10mg, in the acute treatment of migraine, showed that they were indistinguishable in terms of time to pain free - the primary end-point of this trial.1
The study, presented at the 9th International Headache Society’s Congress in Barcelona, Spain, confirmed the rapid and high efficacy of Zomig 2.5mg.

Although an adjusted sub-group analysis had been used to claim that there was a significant difference between Zomig and rizatriptan, during the presentation of the data it was confirmed that when all patients were considered there was no significant difference between the two treatments in terms of time to pain free.

Dr. Alan Rapoport, Director of The New England Headache Center, Stamford, CT, re-affirmed that "Zomig provides the complete triptan profile: rapid, reliable, long-lasting, well-tolerated relief of migraine headache."

Related Link: Zomig

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities